Core Insights - The report highlights the growth in China's instrument manufacturing industry, with a notable increase in export value projected for 2025 [1][2]. Group 1: Industry Overview - The total export value of China's instrument manufacturing industry is expected to reach 14.05 billion yuan in July 2025, reflecting a year-on-year growth of 3.8% [1]. - Cumulatively, from January to July 2025, the export value is projected to be 95.61 billion yuan, with a year-on-year increase of 11.7% [1]. Group 2: Companies Mentioned - The companies listed include Chuangyuan Xinke (831961), Audiwei (832491), Tonghui Electronics (833509), Haineng Technology (430476), Xinzhilife (430685), Bikang Instruments (830879), Tiangang Co., Ltd. (832651), Chicheng Co., Ltd. (834407), and Laisai Laser (871263) [1].

东方证券股份有限公司关于 海能未来技术集团股份有限公司 2025 年半年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《北京证券交易所股票上市规则》 等有关法律法规、规范性文件等的规定，东方证券股份有限公司作为海能未来技 术集团股份有限公司的保荐机构，负责海能未来技术集团股份有限公司的持续督 导工作，并出具 2025 年半年度持续督导跟踪报告。 | 项目 | 工作内容 | | --- | --- | | 1.审阅公司信息披露文件 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 无 | | 2.督导公司建立健全并有效执行规则制度 | | | （1）是否督导公司建立健全规则制度（包括但 | | | 不限于公司治理制度、财务内控制度和信息披 | 是 | | 露制度等） | | | （2）公司是否有效执行相关规则制度 | 是 | | 3.募集资金使用监督 | | | （1）查询公司募集资金专户次数 | 每月一次 | | （2）公司募集资金项目进展是否与信息披露文 | 是 | | 件一致 | | | 4.督导公司规范运作 | | | （1）列席公司股 ...

证券代码：430476 证券简称：海能技术 公告编号：2025-127 海能未来技术集团股份有限公司 回购进展情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 本次回购方式为竞价方式回购。 一、 回购方案基本情况 (一)审议及表决情况 海能未来技术集团股份有限公司（以下简称"公司"）于 2025 年 3 月 20 日召开了 第五届董事会第五次临时会议、第五届监事会第三次临时会议，审议通过了《关于以集 中竞价交易方式回购公司股份方案的议案》。 (二)回购用途及目的 基于对公司未来发展的信心及公司价值的认可，为维护广大投资者的利益，增强投 资者信心，推进股票价值与公司内在价值相匹配，提升公司股票长期投资价值，公司积 极响应党中央、国务院决策部署，根据中国人民银行、金融监管总局、中国证监会《关 于设立股票回购增持再贷款有关事宜的通知》，公司决定以自有资金及银行提供的股票 回购专项贷款资金回购公司股份。 本次回购的股份将用于实施股权激励，以引进和稳定优秀经营管理人才，提升经营 管理团队的凝聚力，推进长期激 ...

Summary of Haineng Technology Conference Call Company Overview - **Company**: Haineng Technology - **Industry**: Scientific Instruments Key Points and Arguments 1. **Revenue Growth**: In the first half of 2025, Haineng Technology's revenue increased by 34% year-on-year, driven by the introduction of new products such as chromatography and spectroscopy series, as well as significant R&D investments [2][4][3] 2. **Profitability**: The company turned a profit with a net income exceeding 5 million yuan, marking an increase of over 20 million yuan compared to the same period last year. The gross margin remained around 65% due to prior industry positioning and optimization of expense structures [2][4][3] 3. **Share Buyback**: Haineng Technology has completed over 30 million yuan in share buybacks and adjusted the buyback limit to 25 yuan to manage market capitalization [2][5] 4. **Market Coverage**: The company's products span various sectors including marine machinery, equipment, food, environment, biopharmaceuticals, and basic research, although precise revenue contributions from marine-related sectors are difficult to quantify [2][6] 5. **Domestic Policy Impact**: The "first set" policy has encouraged domestic replacements for imported products, significantly boosting sales of liquid chromatography and other products, particularly in the pharmaceutical sector [2][9][10] 6. **International Expansion**: Haineng Technology's overseas business has grown rapidly, especially in underdeveloped regions such as Southeast Asia, the Middle East, Russian-speaking areas, and South America, with a strategy to establish a presence in developing countries before moving to developed markets [2][11][12] 7. **Future Performance Outlook**: The company expects to maintain over 30% growth in the second half of 2025, with overall performance anticipated to surpass levels from 2024 and 2023, driven by product maturity and increased customer recognition [3][13] 8. **Market Dynamics**: The scientific instruments industry is characterized by gradual growth rather than explosive increases, with the marine economy potentially driving related business but overall growth remaining steady and less affected by macroeconomic fluctuations [7][8] Additional Important Insights 1. **Product Development**: Haineng Technology has made substantial investments in new product development and quality improvements, which have contributed to the strong revenue growth despite challenging macro conditions [4][13] 2. **Customer Segmentation**: The company serves a diverse customer base, including government agencies, research institutions, and various industries, making it challenging to isolate marine economy-related revenue [8] 3. **Long-term Confidence**: Haineng Technology expresses confidence in its long-term development, supported by domestic policy and international market expansion efforts [14]

Summary of Key Points Core Viewpoint - A total of 18 companies have raised their share repurchase price limits since July, reflecting an improvement in market conditions and increased investor confidence, with some companies raising their repurchase prices by over 140% [1][6]. Group 1: Companies Adjusting Repurchase Prices - On August 26, companies such as Jinli Permanent Magnet, Jinchun Co., Toukeng Life, and Kesi Technology announced increases in their share repurchase price limits [1]. - Jinli Permanent Magnet raised its repurchase price limit from 31.06 CNY/share to 42.66 CNY/share, an increase of 37.35% [2]. - Jinchun Co. increased its limit from 17.90 CNY/share to 35 CNY/share, marking a 95.53% rise [2]. - Toukeng Life adjusted its limit from 15.85 CNY/share to 29.34 CNY/share, an 85.11% increase [2]. - Kesi Technology raised its limit from 53.86 CNY/share to 102 CNY/share, an increase of 89.38% [2]. Group 2: Market Trends and Implications - The average increase in repurchase prices among the 18 companies is 61.5% [6]. - The rise in repurchase prices is attributed to two main factors: the recovery of the market and the companies' confidence in their future stability and intrinsic value [4][6]. - Companies are utilizing special loans to support their repurchase plans, as seen with Aoshikang, which secured a loan of up to 162 million CNY for its repurchase [8]. Group 3: Regulatory and Market Environment - The Chinese government has encouraged companies to use repurchase and increase strategies to enhance market stability [8]. - Industry experts suggest that companies should carefully evaluate and dynamically adjust their repurchase plans to ensure effective implementation and bolster market confidence [9].

证券代码：430476 证券简称：海能技术 公告编号：2025-125 海能未来技术集团股份有限公司 第一章 总则 第一条 为维护公司、股东、职工和债权人的合法权益，规范公司的组织和行为， 根据《中华人民共和国公司法》(以下简称"《公司法》")《中华人民共和国证券法》 (以下简称"《证券法》")和其他有关规定，制订本章程。 第二条 公司系依照《公司法》《证券法》和其他有关规定由原济南海能仪器有 限公司以账面净资产折股整体变更方式发起设立的股份有限公司，原有限公司的股 东为公司的发起人。 公司登记机关为济南高新技术产业开发区管委会，统一社会信用代码为 913701007926213730。 第三条 公司于 2022 年 9 月 2 日经中国证券监督管理委员会[2022]2023 号文批 复同意注册，向不特定合格投资者公开发行普通股 10,000,000 股，于 2022 年 10 月 14 日在北京证券交易所上市。 第四条 公司名称：海能未来技术集团股份有限公司 章 程 二零二五年八月修订 | 第一章 总则 3 | | | | | --- | --- | --- | --- | | 第二章 经营宗旨和范围 4 ...

2025 年第一次临时股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 海能未来技术集团股份有限公司 一、会议召开和出席情况 证券代码：430476 证券简称：海能技术 公告编号：2025-124 （一）会议召开情况 1.会议召开时间：2025 年 8 月 27 日 2.会议召开地点：山东省德州市临邑县花园东大街 16 号公司会议室 3.会议召开方式：现场投票和网络投票相结合方式 4.会议召集人：董事会 5.会议主持人：董事长张振方先生 6.召开情况合法合规的说明： 2025 年 8 月 12 日，海能未来技术集团股份有限公司(以下简称"公司")召 开了第五届董事会第九次会议，会议审议通过了《关于提请召开 2025 年第一次 临时股东会的议案》。本次股东会的召开符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定，无需相关部门的批准或履行必要程序。 （二）会议出席情况 出席和授权出席本次股东会的股东共 26 人，持有表决权的股份总数 28,287,473 股，占公司有表决权股 ...

Group 1 - The Beijiao Stock Exchange's Beijiao 50 Index successfully crossed the 1600-point mark for the third time in five trading days, indicating a strong market performance [1] - The Beijiao 50 Index experienced a significant increase of 100.30 points or 6.79% on August 18, reaching a historical high of 1637.50 points the following day [1] - Analysts expect the Beijiao 50 Index to find a new equilibrium between 1450 and 1650 points after breaking the critical 1500-point level [1][2] Group 2 - Multiple factors, including policy environment, capital allocation, industry trends, and performance validation, have contributed to the strong breakout of the Beijiao 50 Index [2] - As of August 22, 65% of the 106 companies listed on the Beijiao Stock Exchange reported positive revenue growth, with 58% showing positive net profit growth [2] - Companies such as Jinbo Bio, Guangxin Technology, and Minshida reported revenue and net profit growth exceeding 20%, with some planning mid-term dividends to reward investors [2] Group 3 - The Beijiao Stock Exchange is well-aligned with the national strategy of "new quality productivity," focusing on high-end manufacturing, information technology, and biomedicine [2][3] - The market is expected to see a long-term trend of performance and index resonance, driven by the increasing quality of listed companies and the ongoing institutional reforms in the capital market [3] Group 4 - The A-share market has shown signs of a bull market, with indices reaching new highs and trading volumes frequently exceeding 2 trillion yuan [4] - Public funds have increased their holdings in Beijiao-listed companies, with 39 funds holding nearly 10 billion yuan in total, marking a three-year high in institutional participation [4] - Analysts predict that nearly 10 billion yuan in institutional funds will enter the Beijiao Stock Exchange in the second half of the year, with new index funds expected to enhance market liquidity [4] Group 5 - The Beijiao Stock Exchange is anticipated to maintain high trading activity and market attention due to the introduction of specialized indices and steady new stock issuances [5] - Market sentiment is expected to influence short-term volatility, but the slow bull market trend remains intact, supported by macro policies favoring technological innovation [5]

Group 1: Market Trends and Institutional Interest - During the 2025 semi-annual report disclosure period, there has been a surge in institutional research activities focused on companies listed on the Beijing Stock Exchange, with over 20 companies, including Mingyang Technology and Fujida, releasing investor relations activity records since August [1] - The research topics primarily revolve around corporate performance growth drivers, new product layouts, capacity expansion, and overseas market development, indicating a strong willingness for development among companies [1] Group 2: Technological Advancements and Strategic Planning - Institutional inquiries have delved into technical details and strategic planning, such as the progress of 6G technology research by Chuangyuan Xinke, which has passed acceptance tests for a project in collaboration with the Chinese Academy of Sciences [2] - Companies like BiKang Instruments have highlighted their product designs that can withstand extreme environments, showcasing their commitment to technical excellence [2] Group 3: High-End Manufacturing and Order Conversion - LinTai New Materials is the only domestic supplier in the wet paper-based friction materials sector, indicating high barriers to entry due to long certification cycles and tight customer binding [3] - ZhuoZhao Adhesive has achieved breakthroughs in the non-fruit chain market, securing multi-million level mass production orders in the Meta AI glasses sector [3] - Mingyang Technology reported a 93% year-on-year increase in revenue from seat adjustment assemblies, focusing on core products while investing in new product development despite short-term margin pressures [3] Group 4: Capacity Expansion and Market Development - Jianbang Technology reported that nearly half of its revenue comes from overseas, with a 183.18% increase in sales revenue from non-automotive parts, indicating resilience amid complex international conditions [4] - Huaguang Source Sea has entered the bulk commodity logistics sector through acquisitions, aligning with national strategies for low-altitude economic development [4] Group 5: Technological Upgrades and Operational Efficiency - Taihu Xue has successfully implemented a dual-engine marketing strategy on Douyin, achieving a 59.62% year-on-year revenue growth, while also expanding production capacity through the "Future Factory" project [5] - Haineng Technology has established a "Large Model Intelligent Operations Department" to integrate intelligent technology with business scenarios, aiming for a closed-loop upgrade from data assetization to business intelligence [5] Group 6: Pharmaceutical Innovations - Zimu Gong Pharmaceutical has initiated Phase Ia clinical trials for its new drug, emphasizing its comprehensive layout in the traditional Chinese medicine industry [6] - Yiyuan Pharmaceutical has upgraded its fundraising project to expand production capacity for various raw materials, aiming to build a complete pharmaceutical manufacturing chain [6]

Group 1: Institutional Research and Focus Areas - During the 2025 semi-annual report disclosure period, companies listed on the Beijing Stock Exchange are experiencing a surge in institutional research activities, with over 20 companies, including Mingyang Technology and Fujida, releasing investor relations activity records since August [1] - The focus of the research includes corporate performance growth drivers, new product layouts, capacity expansion, and overseas market development, with many companies indicating a commitment to increasing R&D investment in high-potential sectors such as new energy and semiconductors [1][2] - Various institutions, including Huayuan Securities and Tiger Pacific Capital, are participating in the research, reflecting a growing recognition of quality companies on the Beijing Stock Exchange by institutional investors [1] Group 2: Technological Advancements and Market Expansion - Companies are not only focusing on financial performance but also delving into technical details and strategic planning during institutional research [2] - Lin Tai New Materials, as the only domestic supplier in the wet paper-based friction materials sector, highlights high barriers to entry, with its electronic control differential lock already receiving project designations from major companies [3] - Mingyang Technology reported a 93% year-on-year increase in revenue from seat adjustment assemblies, focusing on core products while continuing to invest in new product development despite short-term margin pressures [3] Group 3: Capacity Expansion and New Market Ventures - Jianbang Technology reported that nearly half of its revenue comes from overseas, achieving double-digit growth in both revenue and profit, with significant sales growth in non-automotive parts [4] - Huaguang Source Sea is expanding its business boundaries by acquiring logistics companies and investing in low-altitude industry funds, aligning with national strategies for low-altitude economic development [4] Group 4: R&D and Intelligent Upgrades - Companies are actively pursuing technological upgrades and system adaptations to enhance operational efficiency and market competitiveness [6] - Taihu Snow's online channel strategy has led to a 59.62% year-on-year revenue increase, while its "Future Factory" project aims to achieve integrated operations in smart manufacturing and cross-border services [6] - Hai Neng Technology is establishing a "Large Model Intelligent Operations Department" to integrate intelligent technology with business scenarios, focusing on software autonomy and data security [6] Group 5: Pharmaceutical Innovations - Zizhong Palace Pharmaceutical has initiated Phase Ia clinical trials for its new drug, emphasizing its comprehensive layout in the traditional Chinese medicine industry [7] - Fangyi Pharmaceutical is upgrading its fundraising project to expand its production capacity for various raw materials, aiming to build a complete pharmaceutical manufacturing chain [7]